CMPS
COMPASS Pathways plc
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Neutral
+7/100
Last price
11.78
▲ 0.22 (1.90%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
11.55
Prev close
11.56
Day high
11.86
Day low
11.45
Volume
603.00K
Market cap
$1.63B
P/E (TTM)
—
52W range
4.88 – 15.87
Day trading desk
Gap from prior close
-0.06%
Prior close 11.56
VWAP
11.70
+0.66% from price
Relative volume
0.19×
Quiet session
Session range
4.22%
11.38 – 11.86
Position in range
83%
Near session high
ATR (14D)
0.66
5.56% of price
Prior day high
11.80
PDH
Prior day low
11.17
PDL
Bid / ask spread
—
Quote not published
Session volume
602.69K
Avg 3.13M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-5.31%
-7.1%
1M
-16.10%
-17.5%
3M
-13.38%
-16.7%
6M
+105.94%
+91.1%
YTD
+70.72%
+56.9%
1Y
+87.28%
+71.7%
3Y
+71.47%
-10.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on CMPS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
10.56M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Mar 26, 26 | NATH KABIR Chief Executive Officer |
STOCK | 175.00K | $0 | Direct |
| Mar 26, 26 | LOXAM TERI Chief Financial Officer |
STOCK | 75.00K | $0 | Direct |
| Mar 11, 25 | LOXAM TERI Chief Financial Officer |
STOCK | 25.00K | $0 | Direct |
| Oct 24, 24 | GOLDSMITH GEORGE JAY Beneficial Owner of more than 10% of a Class of Security |
SELL | 776.57K | $4.99M | |
| Oct 24, 24 | MALIEVSKAIA EKATERINA Beneficial Owner of more than 10% of a Class of Security |
SELL | 1.55M | $9.99M |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
GOLDSMITH GEORGE JAY |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
LOXAM TERI |
Chief Financial Officer | 152.00K | Stock Award(Grant) |
MALIEVSKAIA EKATERINA |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
NATH KABIR |
Chief Executive Officer | 366.99K | Stock Award(Grant) |
Fundamentals
Market cap$1.63B
Enterprise value$1.22B
Revenue (TTM)—
Gross profit—
EBITDA$-185.56M
Net income$-394.19M
EPS (TTM)$-3.76
Free cash flow$249.95M
Total cash$433.30M
Total debt$54.63M
Book value / share$0.62
Shares outstanding138.48M
Float106.97M
Short % of float11.14%
Dividend yield0.00%
Beta (5Y)2.56
Valuation & profitability ratios
Trailing P/E—
Forward P/E-8.22
PEG ratio—
Price / sales—
Price / book18.91
EV / revenue—
EV / EBITDA-6.59
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on equity-319.07%
Return on assets-29.08%
Debt / equity64.62
Current ratio1.30
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | — |
| Research & development | $118.44M | $119.04M | $87.52M | $65.05M | -0.5% |
| Selling, general & admin | $60.60M | $59.17M | $49.40M | $45.35M | +2.4% |
| Total operating expense | $175.29M | $157.11M | $124.04M | $95.98M | +11.6% |
| Operating income | -$175.29M | -$157.11M | -$124.04M | -$95.98M | -11.6% |
| Net interest income | $2.67M | $3.79M | $2.42M | $0 | -29.7% |
| Pre-tax income | -$290.33M | -$153.53M | -$117.68M | -$91.10M | -89.1% |
| Tax provision | -$2.47M | $1.59M | $780.00K | $408.00K | -255.1% |
| Net income | -$287.86M | -$155.12M | -$118.46M | -$91.50M | -85.6% |
| Net income to common | -$287.86M | -$155.12M | -$118.46M | -$91.50M | -85.6% |
| Basic EPS | -3.08 | -2.30 | -2.32 | -2.16 | -33.9% |
| Diluted EPS | -3.08 | -2.30 | -2.32 | -2.16 | -33.9% |
| EBIT | -$285.82M | -$149.05M | -$115.48M | -$91.10M | -91.8% |
| EBITDA | -$285.60M | -$148.82M | -$115.24M | -$90.77M | -91.9% |
| Basic shares | 93.50M | 67.48M | 67.48M | 42.44M | +38.6% |
| Diluted shares | 93.50M | 67.48M | 67.48M | 42.44M | +38.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $149.61M | $165.08M | $220.20M | $143.21M | -9.4% |
| Cash & short-term investments | $149.61M | $165.08M | $220.20M | $143.21M | -9.4% |
| Total current assets | $191.49M | $201.29M | $261.30M | $191.65M | -4.9% |
| Property, plant & equipment | $3.42M | $2.01M | $4.73M | $2.62M | +70.7% |
| Total assets | $210.35M | $213.67M | $275.99M | $197.29M | -1.6% |
| Total current liabilities | $247.79M | $34.02M | $19.60M | $15.60M | +628.5% |
| Current debt | $17.52M | $5.51M | — | — | +217.8% |
| Long-term debt | $14.11M | $24.65M | $28.76M | — | -42.8% |
| Total debt | $35.03M | $32.19M | $33.05M | $1.93M | +8.8% |
| Total liabilities | $263.20M | $58.97M | $50.24M | $16.01M | +346.3% |
| Retained earnings | -$822.59M | -$534.73M | -$379.61M | -$261.15M | -53.8% |
| Shareholder equity | -$52.85M | $154.69M | $225.74M | $181.28M | -134.2% |
| Working capital | -$56.30M | $167.28M | $241.69M | $176.06M | -133.7% |
| Net tangible assets | -$52.85M | $154.69M | $225.74M | $181.28M | -134.2% |
| Shares issued | 96.09M | 68.55M | 61.94M | 42.63M | +40.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$287.86M | -$155.12M | -$118.46M | -$91.50M | — | -85.6% |
| Depreciation & amortisation | $216.00K | $233.00K | $242.00K | $330.00K | — | -7.3% |
| Stock-based compensation | $13.59M | $19.52M | $17.28M | $13.12M | — | -30.4% |
| Change in working capital | -$14.25M | $11.72M | $3.48M | -$30.67M | — | -221.5% |
| Operating cash flow | -$157.24M | -$119.19M | -$97.38M | -$105.45M | — | -31.9% |
| Capital expenditure | — | — | -$66.00K | -$596.00K | -$334.00K | — |
| Investing cash flow | — | $0 | -$64.00K | -$596.00K | -$334.00K | — |
| Financing cash flow | $140.71M | $63.82M | $173.83M | $1.04M | — | +120.5% |
| Free cash flow | -$157.24M | -$119.19M | -$97.44M | -$106.05M | — | -31.9% |
| End cash position | $149.99M | $165.47M | $220.64M | $143.38M | — | -9.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | $0 | — |
| Research & development | $29.18M | $26.48M | $29.91M | $27.32M | $30.32M | +10.2% |
| Selling, general & admin | $23.20M | $16.42M | $16.05M | $13.21M | $12.61M | +41.2% |
| Total operating expense | $49.79M | $40.43M | $58.86M | $36.61M | $38.65M | +23.2% |
| Operating income | -$49.79M | -$40.43M | -$58.86M | -$36.61M | -$38.65M | -23.2% |
| Net interest income | $2.26M | $954.00K | $173.00K | $483.00K | $747.00K | +137.0% |
| Pre-tax income | -$253.46M | $91.19M | -$96.61M | -$137.95M | -$38.27M | -377.9% |
| Tax provision | $331.00K | -$11.00K | -$2.73M | -$230.00K | $137.00K | +3,109.1% |
| Net income | -$253.79M | $91.20M | -$93.88M | -$137.72M | -$38.40M | -378.3% |
| Net income to common | -$253.79M | $77.64M | -$93.88M | -$137.72M | -$38.40M | -426.9% |
| Basic EPS | -1.88 | 0.71 | -1.00 | -1.44 | -0.41 | -364.8% |
| Diluted EPS | -1.88 | -0.30 | -1.00 | -1.44 | -0.41 | -526.7% |
| EBIT | -$251.98M | $92.66M | -$95.47M | -$136.84M | -$37.12M | -372.0% |
| EBITDA | -$251.98M | $92.66M | -$95.47M | -$136.83M | -$36.96M | -372.0% |
| Basic shares | 135.04M | 110.06M | 93.64M | 95.34M | 93.34M | +22.7% |
| Diluted shares | 135.04M | 130.27M | 93.64M | 95.34M | 93.34M | +3.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $433.30M | $466.01M | $149.61M | $185.94M | $221.88M | — | -7.0% |
| Cash & short-term investments | $433.30M | $466.01M | $149.61M | $185.94M | $221.88M | — | -7.0% |
| Total current assets | $475.67M | $510.87M | $191.49M | $242.39M | $276.40M | — | -6.9% |
| Property, plant & equipment | $3.94M | $2.86M | $3.42M | $3.93M | $4.34M | — | +37.6% |
| Total assets | $504.56M | $531.74M | $210.35M | $255.61M | $293.54M | — | -5.1% |
| Total current liabilities | $367.29M | $153.80M | $247.79M | $197.45M | $31.33M | — | +138.8% |
| Current debt | — | — | $17.52M | $12.67M | $7.98M | $8.99M | — |
| Long-term debt | $50.73M | $50.48M | $14.11M | $18.60M | $22.95M | — | +0.5% |
| Total debt | $54.63M | $53.31M | $35.03M | $35.18M | $35.29M | — | +2.5% |
| Total liabilities | $420.03M | $205.05M | $263.20M | $218.02M | $130.98M | — | +104.8% |
| Retained earnings | -$985.19M | -$731.39M | -$822.59M | -$728.72M | -$591.00M | — | -34.7% |
| Shareholder equity | $84.53M | $326.69M | -$52.85M | $37.59M | $162.56M | — | -74.1% |
| Working capital | $108.39M | $357.07M | -$56.30M | $44.94M | $245.07M | — | -69.6% |
| Net tangible assets | $84.53M | $326.69M | -$52.85M | $37.59M | $162.56M | — | -74.1% |
| Shares issued | 134.95M | 134.92M | 96.09M | 96.00M | 93.59M | — | +0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$253.79M | $91.20M | -$93.88M | -$137.72M | -$38.40M | -378.3% |
| Depreciation & amortisation | $0 | $0 | $6.00K | $15.00K | $158.00K | — |
| Stock-based compensation | $4.03M | $2.90M | $2.85M | $3.21M | $3.60M | +39.1% |
| Change in working capital | $3.24M | -$11.26M | $13.88M | -$3.41M | -$7.08M | +128.7% |
| Operating cash flow | -$40.31M | -$47.94M | -$37.79M | -$35.11M | -$38.69M | +15.9% |
| Financing cash flow | $7.56M | $362.45M | $187.00K | $0 | $166.00K | -97.9% |
| Free cash flow | -$40.31M | -$47.94M | -$37.79M | -$35.11M | -$38.69M | +15.9% |
| End cash position | $433.72M | $466.39M | $149.99M | $186.32M | $222.26M | -7.0% |
Options analytics
Put / call volume
10.88
Put-heavy session
Put / call open interest
0.51
Positioning, not flow
Max pain
14.00
+18.8% from spot
ATM implied vol
67.2%
Nearest strike to spot
Skew (10% OTM)
-15.6%
Calls bid over puts
Call volume
193
Contracts, this expiry
Put volume
2.10K
Contracts, this expiry
Heaviest call OI
17.00
4.79K contracts
Heaviest put OI
13.00
2.56K contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.34 | -0.36 | -6.6% |
| Mar 2026 | -0.32 | -0.31 | +3.2% |
| Dec 2025 | -0.39 | -0.61 | -55.5% |
| Sep 2025 | -0.41 | -0.38 | +5.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.33 | 4 | $0 | 0.0% |
| Next quarter | -0.39 | 4 | $0 | 0.0% |
| Current year | -1.51 | 4 | $0 | 0.0% |
| Next year | -1.43 | 3 | $39.70M | 0.0% |
Analyst targets & ownership
Mean target$23.75
High target$65.00
Low target$13.00
Implied upside101.61%
Analyst count16
ConsensusSTRONG BUY
Strong buy / Buy3 / 12
Hold1
Sell / Strong sell0 / 0
Held by insiders7.62%
Held by institutions68.58%
Institutions holding263
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
12.36
-4.67% from price
SMA 20
13.40
-12.10% from price
SMA 50
13.39
-12.05% from price
SMA 100
12.90
-8.65% from price
SMA 200
10.01
+17.67% from price
EMA 12
12.52
-5.90% from price
EMA 26
13.08
-9.91% from price
EMA 50
13.12
-10.21% from price
RSI (14)
35.7
Neutral
MACD (12,26,9)
-0.56
Hist -0.27
ATR (14)
0.66
5.56% of price
Realised vol 30D
57.7%
Annualised
Bollinger upper
15.79
20, 2σ
Bollinger lower
11.01
20, 2σ
50 / 200 cross
Golden
13.39 vs 10.01
Trend bias
Above 200
+17.67%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.46
More volatile than market
Correlation to SPY
0.21
Largely independent
Realised vol 30D
57.7%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-38.2%
Peak to trough
Max drawdown 5Y
-95.2%
Peak to trough
ATR 14
0.66
5.56% of price
Beta (reported)
2.56
5Y monthly, from filing
Short interest
Shares short
15.24M
Prior 14.10M
Change vs prior
+8.1%
Shorts adding
% of float
11.14%
Elevated
% of shares out
11.00%
Against total outstanding
Days to cover
6.1
Crowded exit
Float
106.97M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Aug 6, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Aug 6, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Aug 6, 26 | B. Riley Securities | MAINTAINED | Buy | Buy |
| Jul 27, 26 | Wells Fargo | INITIATED | — | Equal-Weight |
| Jul 8, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jul 8, 26 | Evercore ISI Group | UPGRADE | In-Line | Outperform |
| Jul 8, 26 | Stifel | MAINTAINED | Buy | Buy |
| Jul 7, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Jul 7, 26 | Oppenheimer | MAINTAINED | Outperform | Outperform |
| Jul 7, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jun 26, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Offering Registrations
S-3ASR · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-07-07
Corporate Changes & Voting Matters
8-K · 2026-05-28
Periodic Financial Reports
10-Q · 2026-05-13
Annual Report to Shareholders
ARS · 2026-04-15
Corporate Changes & Voting Matters
8-K · 2026-03-24
Corporate Changes & Voting Matters
8-K · 2026-01-07
Periodic Financial Reports
10-Q · 2025-11-04
Headlines
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire · 5d ago
COMPASS Pathways (CMPS) Could Be 49% Below Fair Value Following Its Phase III Progress
Simply Wall St. · 7d ago
Compass Pathways Appoints Kelley Boucher as Chief People Officer
Business Wire · 7d ago
Compass Pathways Targets Q4 COMP360 NDA Completion, Eyes 2027 Launch
MarketBeat · 13d ago
Helus Pharma Eyes Q4 Phase III Data for HLP-003 in Major Depression
MarketBeat · 13d ago
Compass Pathways Targets 2027 COMP360 Launch After Positive Phase III Depression Data
MarketBeat · 15d ago
Compass Pathways Eyes 2027 COMP360 Launch as FDA Review Advances
MarketBeat · 15d ago
Cybin Shareholders Weigh Helus Pharma Rebrand, Eight-Member Board
MarketBeat · 15d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.